Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients
To evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thicknesses with macular and peripapillary VD; and to evaluate the diagnostic accuracy of...
Saved in:
Published in | Investigative ophthalmology & visual science Vol. 58; no. 13; p. 5713 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.11.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thicknesses with macular and peripapillary VD; and to evaluate the diagnostic accuracy of the structural and vascular parameters.
A consecutive series of GS, glaucoma patients, and healthy subjects was prospectively recruited from July 1, 2016, to January 31, 2017. All subjects underwent standard automated perimetry, spectral-domain optical coherence tomography (OCT), and 6 × 6-mm optical coherence tomography angiography (OCT-A) centered on the fovea and optic nerve.
Forty controls, 40 GS, and 40 glaucoma patients were enrolled. Peripapillary RNFL, GCIPL, and macular RNFL thicknesses significantly decreased in the glaucoma group compared to controls and GS (P < 0.01). Peripapillary VD in average and in the superior and inferior quadrants decreased in the glaucoma group (P ≤ 0.001); conversely, macular VD was not statistically different across groups (P > 0.05). At the peripapillary area, a correlation between RNFL thickness and VD was found; conversely, no statistically significant correlation was found between GCIPL thicknesses and macular VD (all P > 0.05) in all groups. Peripapillary RNFL and GCIPL showed higher diagnostic capacity compared to peripapillary and macular VDs.
Structural damage is evident both in the peripapillary and in macular areas. Vascular damage seems to be less prominent, as it was seen only for the glaucoma group and at the radial peripapillary plexus. Diagnostic abilities are excellent for structural variables, less so but still good for peripapillary VD, and poor for macular VD. |
---|---|
AbstractList | To evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thicknesses with macular and peripapillary VD; and to evaluate the diagnostic accuracy of the structural and vascular parameters.PurposeTo evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thicknesses with macular and peripapillary VD; and to evaluate the diagnostic accuracy of the structural and vascular parameters.A consecutive series of GS, glaucoma patients, and healthy subjects was prospectively recruited from July 1, 2016, to January 31, 2017. All subjects underwent standard automated perimetry, spectral-domain optical coherence tomography (OCT), and 6 × 6-mm optical coherence tomography angiography (OCT-A) centered on the fovea and optic nerve.MethodsA consecutive series of GS, glaucoma patients, and healthy subjects was prospectively recruited from July 1, 2016, to January 31, 2017. All subjects underwent standard automated perimetry, spectral-domain optical coherence tomography (OCT), and 6 × 6-mm optical coherence tomography angiography (OCT-A) centered on the fovea and optic nerve.Forty controls, 40 GS, and 40 glaucoma patients were enrolled. Peripapillary RNFL, GCIPL, and macular RNFL thicknesses significantly decreased in the glaucoma group compared to controls and GS (P < 0.01). Peripapillary VD in average and in the superior and inferior quadrants decreased in the glaucoma group (P ≤ 0.001); conversely, macular VD was not statistically different across groups (P > 0.05). At the peripapillary area, a correlation between RNFL thickness and VD was found; conversely, no statistically significant correlation was found between GCIPL thicknesses and macular VD (all P > 0.05) in all groups. Peripapillary RNFL and GCIPL showed higher diagnostic capacity compared to peripapillary and macular VDs.ResultsForty controls, 40 GS, and 40 glaucoma patients were enrolled. Peripapillary RNFL, GCIPL, and macular RNFL thicknesses significantly decreased in the glaucoma group compared to controls and GS (P < 0.01). Peripapillary VD in average and in the superior and inferior quadrants decreased in the glaucoma group (P ≤ 0.001); conversely, macular VD was not statistically different across groups (P > 0.05). At the peripapillary area, a correlation between RNFL thickness and VD was found; conversely, no statistically significant correlation was found between GCIPL thicknesses and macular VD (all P > 0.05) in all groups. Peripapillary RNFL and GCIPL showed higher diagnostic capacity compared to peripapillary and macular VDs.Structural damage is evident both in the peripapillary and in macular areas. Vascular damage seems to be less prominent, as it was seen only for the glaucoma group and at the radial peripapillary plexus. Diagnostic abilities are excellent for structural variables, less so but still good for peripapillary VD, and poor for macular VD.ConclusionsStructural damage is evident both in the peripapillary and in macular areas. Vascular damage seems to be less prominent, as it was seen only for the glaucoma group and at the radial peripapillary plexus. Diagnostic abilities are excellent for structural variables, less so but still good for peripapillary VD, and poor for macular VD. To evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thicknesses with macular and peripapillary VD; and to evaluate the diagnostic accuracy of the structural and vascular parameters. A consecutive series of GS, glaucoma patients, and healthy subjects was prospectively recruited from July 1, 2016, to January 31, 2017. All subjects underwent standard automated perimetry, spectral-domain optical coherence tomography (OCT), and 6 × 6-mm optical coherence tomography angiography (OCT-A) centered on the fovea and optic nerve. Forty controls, 40 GS, and 40 glaucoma patients were enrolled. Peripapillary RNFL, GCIPL, and macular RNFL thicknesses significantly decreased in the glaucoma group compared to controls and GS (P < 0.01). Peripapillary VD in average and in the superior and inferior quadrants decreased in the glaucoma group (P ≤ 0.001); conversely, macular VD was not statistically different across groups (P > 0.05). At the peripapillary area, a correlation between RNFL thickness and VD was found; conversely, no statistically significant correlation was found between GCIPL thicknesses and macular VD (all P > 0.05) in all groups. Peripapillary RNFL and GCIPL showed higher diagnostic capacity compared to peripapillary and macular VDs. Structural damage is evident both in the peripapillary and in macular areas. Vascular damage seems to be less prominent, as it was seen only for the glaucoma group and at the radial peripapillary plexus. Diagnostic abilities are excellent for structural variables, less so but still good for peripapillary VD, and poor for macular VD. |
Author | Triolo, Giacinto Di Matteo, Federico Fard, Ali Magazzeni, Stephanie Sacconi, Riccardo Querques, Giuseppe Vazquez, Luis E. Barboni, Piero Bandello, Francesco Shemonski, Nathan D. Rabiolo, Alessandro Bettin, Paolo |
Author_xml | – sequence: 1 givenname: Giacinto surname: Triolo fullname: Triolo, Giacinto organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 2 givenname: Alessandro surname: Rabiolo fullname: Rabiolo, Alessandro organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 3 givenname: Nathan D. surname: Shemonski fullname: Shemonski, Nathan D. organization: Carl Zeiss Meditec, Inc., Dublin, California, United States – sequence: 4 givenname: Ali surname: Fard fullname: Fard, Ali organization: Carl Zeiss Meditec, Inc., Dublin, California, United States – sequence: 5 givenname: Federico surname: Di Matteo fullname: Di Matteo, Federico organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 6 givenname: Riccardo surname: Sacconi fullname: Sacconi, Riccardo organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 7 givenname: Paolo surname: Bettin fullname: Bettin, Paolo organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 8 givenname: Stephanie surname: Magazzeni fullname: Magazzeni, Stephanie organization: Carl Zeiss Meditec, Inc., Dublin, California, United States – sequence: 9 givenname: Giuseppe surname: Querques fullname: Querques, Giuseppe organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 10 givenname: Luis E. surname: Vazquez fullname: Vazquez, Luis E. organization: Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, United States – sequence: 11 givenname: Piero surname: Barboni fullname: Barboni, Piero organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy – sequence: 12 givenname: Francesco surname: Bandello fullname: Bandello, Francesco organization: Department of Ophthalmology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29114838$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1LHTEUhoNY6ke7dCtZuujYfNzJx1KurRYsCrXdDpl4opGZZEwywv0p_bfmelWk0E1yeHjOgXPePbQdYgCEDig5plTIrz4-5mMqG8aUaLfQLm1b1rRS8e139Q7ay_meEEYpIx_RDtOULhRXu-jv5VS8NQNexjtIECzg6zjG22SmuxU-Cbf-tf5p7DyYhE24wVeQ_GQmP1Swwn8gZxjW0M3Zx4BPIWRfVtgHfA5mKLX719zfgy35Cz4bzGzjaCrK0watR77hK1M8hJI_oQ_ODBk-v_z76Pf3b9fL8-bi8uzH8uSisVyr0oBeOCaZE6rXRPTGKc1Vr4AQ67juuZZayPoAkY4aZ51VzhDohWStWvAF30dHm7lTig8z5NKNPluoqwWIc-6oFlS1SmhR1cMXde5HuOmm5Md6gO71nFVoNoJNMecE7k2hpFvH1a3j6qjsnuOqPv_Ht77U_WMoyfjhP11PpUqcfg |
CitedBy_id | crossref_primary_10_1146_annurev_vision_100419_111350 crossref_primary_10_1080_01658107_2018_1488175 crossref_primary_10_1371_journal_pone_0246469 crossref_primary_10_1016_j_xops_2023_100358 crossref_primary_10_53432_2078_4104_2021_20_3_59_77 crossref_primary_10_3390_jcm11216484 crossref_primary_10_1364_BOE_431888 crossref_primary_10_1167_tvst_10_14_20 crossref_primary_10_3390_vision7030048 crossref_primary_10_1136_bjophthalmol_2020_316455 crossref_primary_10_1016_j_ogla_2021_09_012 crossref_primary_10_1016_j_pdpdt_2021_102611 crossref_primary_10_1097_ICU_0000000000000475 crossref_primary_10_1177_1120672118805882 crossref_primary_10_3390_biology10060538 crossref_primary_10_1007_s10792_022_02588_9 crossref_primary_10_1080_02713683_2019_1593464 crossref_primary_10_1007_s00417_019_04466_0 crossref_primary_10_3389_fmed_2021_814306 crossref_primary_10_1111_aos_15775 crossref_primary_10_1186_s12886_018_1021_x crossref_primary_10_1016_j_ogla_2021_07_009 crossref_primary_10_1177_1120672119834472 crossref_primary_10_1016_j_ajo_2021_11_028 crossref_primary_10_1016_j_ajo_2022_11_004 crossref_primary_10_1001_jamaophthalmol_2019_4821 crossref_primary_10_1136_bjophthalmol_2019_314086 crossref_primary_10_1016_j_preteyeres_2020_100878 crossref_primary_10_1111_cxo_12833 crossref_primary_10_1007_s10792_020_01643_7 crossref_primary_10_3390_jcm11144159 crossref_primary_10_1080_02713683_2020_1755698 crossref_primary_10_1136_bjophthalmol_2018_313732 crossref_primary_10_3389_fmed_2024_1428850 crossref_primary_10_1016_j_jfo_2018_02_004 crossref_primary_10_1007_s10792_020_01564_5 crossref_primary_10_1371_journal_pone_0205773 crossref_primary_10_1111_aos_14392 crossref_primary_10_3389_fmed_2022_891369 crossref_primary_10_1016_j_ajo_2021_01_015 crossref_primary_10_1016_j_ogla_2023_09_003 crossref_primary_10_3389_fendo_2022_1036735 crossref_primary_10_1080_02713683_2019_1676912 crossref_primary_10_1177_1120672119858891 crossref_primary_10_3892_br_2022_1519 crossref_primary_10_7759_cureus_80583 crossref_primary_10_4274_tjo_galenos_2021_72654 crossref_primary_10_1016_j_ajo_2018_05_029 crossref_primary_10_1111_ceo_13648 crossref_primary_10_3389_fmed_2021_696004 crossref_primary_10_3390_jcm9061706 crossref_primary_10_3390_biomedicines12061211 crossref_primary_10_3390_jcm12052071 crossref_primary_10_1186_s12886_020_01707_3 crossref_primary_10_1177_2515841419899822 crossref_primary_10_1097_IJG_0000000000001463 crossref_primary_10_1097_IJG_0000000000002310 crossref_primary_10_17816_OV630422 crossref_primary_10_1016_j_ajo_2019_09_015 crossref_primary_10_1167_iovs_18_26115 crossref_primary_10_1364_BOE_10_001532 crossref_primary_10_1038_s41598_019_52818_x crossref_primary_10_1038_s41598_020_71757_6 crossref_primary_10_1167_iovs_18_25423 crossref_primary_10_3390_diagnostics13020244 crossref_primary_10_1016_j_jfo_2020_06_038 crossref_primary_10_1111_cxo_13068 crossref_primary_10_3389_fbioe_2023_1086347 crossref_primary_10_1016_j_ajo_2018_05_020 crossref_primary_10_1097_IJG_0000000000001570 crossref_primary_10_1016_j_ajo_2018_11_012 crossref_primary_10_1136_bmjophth_2023_001256 crossref_primary_10_1167_tvst_9_2_58 crossref_primary_10_1097_IJG_0000000000001216 crossref_primary_10_1167_iovs_18_25941 crossref_primary_10_3390_jcm9123854 crossref_primary_10_1109_ACCESS_2024_3434670 crossref_primary_10_1097_IJG_0000000000001857 crossref_primary_10_4103_ijo_IJO_1456_22 crossref_primary_10_1136_bjo_2024_325746 crossref_primary_10_1007_s40135_018_0164_5 crossref_primary_10_4274_tjo_galenos_2022_68302 crossref_primary_10_1007_s11910_024_01343_0 crossref_primary_10_1038_s41598_020_62633_4 crossref_primary_10_1007_s00417_021_05208_x crossref_primary_10_1016_j_ajo_2021_10_005 crossref_primary_10_1136_bjophthalmol_2020_318677 crossref_primary_10_1007_s10792_020_01626_8 crossref_primary_10_1016_j_pdpdt_2024_104271 crossref_primary_10_1167_iovs_18_26099 crossref_primary_10_1167_iovs_19_26848 crossref_primary_10_1136_bjo_2022_322362 crossref_primary_10_3390_jcm12226982 crossref_primary_10_4103_ejos_ejos_18_24 crossref_primary_10_1080_02713683_2018_1438630 crossref_primary_10_1097_IAE_0000000000003795 crossref_primary_10_1016_j_ophtha_2020_12_027 crossref_primary_10_1167_tvst_11_6_27 crossref_primary_10_1007_s10792_019_01238_x crossref_primary_10_1136_bjophthalmol_2020_318449 crossref_primary_10_1038_s41598_023_32164_9 crossref_primary_10_1001_jamaophthalmol_2019_0422 crossref_primary_10_1080_08820538_2024_2343049 crossref_primary_10_1136_bjophthalmol_2018_313461 crossref_primary_10_1159_000533874 crossref_primary_10_1167_iovs_62_10_12 crossref_primary_10_1007_s10384_020_00757_w crossref_primary_10_1186_s12886_019_1146_6 crossref_primary_10_1186_s12886_020_01641_4 crossref_primary_10_3389_fmed_2021_730327 crossref_primary_10_1186_s12886_020_1304_x crossref_primary_10_1016_j_oret_2019_02_002 crossref_primary_10_35119_myjo_v5i1_274 crossref_primary_10_1016_j_ophtha_2019_12_030 crossref_primary_10_1111_aos_14982 crossref_primary_10_1007_s00417_020_04635_6 crossref_primary_10_1016_j_ajo_2019_04_035 crossref_primary_10_1038_s41433_019_0564_2 crossref_primary_10_1167_iovs_18_24891 crossref_primary_10_2147_OPTH_S429718 crossref_primary_10_1111_cxo_12854 crossref_primary_10_1016_j_mbs_2024_109292 crossref_primary_10_1080_02713683_2020_1744164 crossref_primary_10_53432_2078_4104_2024_23_2_95_106 crossref_primary_10_1007_s00417_021_05321_x crossref_primary_10_1177_2474126420953968 crossref_primary_10_24875_RMO_M22000233 crossref_primary_10_1167_tvst_7_6_21 crossref_primary_10_1097_IJG_0000000000001492 crossref_primary_10_1097_IJG_0000000000002069 crossref_primary_10_1080_08164622_2024_2306963 crossref_primary_10_1007_s10792_020_01371_y crossref_primary_10_4103_joco_joco_326_21 crossref_primary_10_1007_s00592_019_01288_8 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1167/iovs.17-22865 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1552-5783 |
ExternalDocumentID | 29114838 10_1167_iovs_17_22865 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- 18M 2WC 34G 39C 5GY 5RE AAYXX ACGFO ACNCT ADBBV AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS BAWUL CITATION CS3 DIK DU5 E3Z EBS EJD F5P GROUPED_DOAJ GX1 N9A OK1 P2P RPM SJN TR2 TRV W8F WH7 WOQ WOW CGR CUY CVF ECM EIF NPM RHF 7X8 |
ID | FETCH-LOGICAL-c398t-e94f272f68b906baf8938b8e00cf39b397967979e07f1afcfc8fa0eb672584343 |
ISSN | 1552-5783 |
IngestDate | Thu Jul 10 18:36:44 EDT 2025 Thu Jan 02 23:03:41 EST 2025 Tue Jul 01 02:30:25 EDT 2025 Thu Apr 24 23:12:44 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c398t-e94f272f68b906baf8938b8e00cf39b397967979e07f1afcfc8fa0eb672584343 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://iovs.arvojournals.org/arvo/content_public/journal/iovs/936568/i1552-5783-58-13-5713.pdf |
PMID | 29114838 |
PQID | 1961858696 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_1961858696 pubmed_primary_29114838 crossref_primary_10_1167_iovs_17_22865 crossref_citationtrail_10_1167_iovs_17_22865 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-11-01 |
PublicationDateYYYYMMDD | 2017-11-01 |
PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Investigative ophthalmology & visual science |
PublicationTitleAlternate | Invest Ophthalmol Vis Sci |
PublicationYear | 2017 |
SSID | ssj0021120 |
Score | 2.5828872 |
Snippet | To evaluate macular and peripapillary vessel perfusion density (VD) in glaucoma suspects (GS) and glaucoma patients; to correlate ganglion cell-inner plexiform... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 5713 |
SubjectTerms | Computed Tomography Angiography Female Glaucoma, Open-Angle - diagnosis Glaucoma, Open-Angle - physiopathology Healthy Volunteers Humans Intraocular Pressure Macula Lutea - blood supply Male Middle Aged Nerve Fibers - pathology Ocular Hypertension - diagnosis Ocular Hypertension - physiopathology Optic Disk - blood supply Perfusion Imaging Prospective Studies Regional Blood Flow - physiology Retinal Ganglion Cells - pathology Retinal Vessels - diagnostic imaging Retinal Vessels - physiology Tomography, Optical Coherence Visual Field Tests |
Title | Optical Coherence Tomography Angiography Macular and Peripapillary Vessel Perfusion Density in Healthy Subjects, Glaucoma Suspects, and Glaucoma Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29114838 https://www.proquest.com/docview/1961858696 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAviDvlMhkJ8dJ2tLk6jxXaNGDteEhR36LEtWmkLInapBL8E_4JP49zbCdNxSYNXqLWSZ2056t9rt8h5J3NJLeYFCPLiW0wUCarEbMx4CphM4L9xZeqF8Fs7p0vnM9Ld9nr_e5kLdVVcsJ_XltX8j9ShTGQK1bJ_oNk20lhAF6DfOEIEobjrWR8WWpPNNZYaLbYsLgyHNSDaf49bV7PYp1uqkoD4MnKuMRuQ5sfg2_IHZ7hoKzRcQYLUK7SNBQHFuaGqcUFvTXah57FNXyVGNN5ymYQp21PfNVMrduu2tth89iJQVGuq3WcXWn6J8TeLt3WTXXmHmrhBmtp1F3TmKd5VeyjUklzapphExekXWidRWsBEjD9uOcqNjDokk5qT3qWdh0esIlOWoeHWaNdsJ993f_mRFwzZhZ2l3UBbHeWadfXb__ePzyMYKfFbnsCN7awbHe_UTbJAfPL6GxxcRGFp8vwDrlrgYGijPlPX1pTf6IJQdvHathdPf_DweSH2tANJo5SdcKH5IGxUehUA-4R6Yn8Mbk3M1kYT8gvgzva4o7ucUc7uKMGdxTkQw9wRzXuaIs7anBH05wa3NEGd0PagIs2qBuqKdvhBnNPyeLsNPx4PjItPkbcDlg1EoEjLd-SHkuCsZfEEtRnljAxHnNpBwkGnT0fDmLsy0ksueRMxmOReL4FmrPt2M_IUV7k4gWhbsDZxFvBCc4dDGaD4i-4ZDxYrezAdvpk2PzUETf899iGJYuUHez5EUommviRkkyfvG8vLzXxy00Xvm3kFsHSjPG2OBdFDVdgNyWXeYHXJ8-1QNuprAAdETZ7eYtPvyL39_-D1-So2tTiDajCVXKsUHesHEl_AE96vZw |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optical+Coherence+Tomography+Angiography+Macular+and+Peripapillary+Vessel+Perfusion+Density+in+Healthy+Subjects%2C+Glaucoma+Suspects%2C+and+Glaucoma+Patients&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Triolo%2C+Giacinto&rft.au=Rabiolo%2C+Alessandro&rft.au=Shemonski%2C+Nathan+D&rft.au=Fard%2C+Ali&rft.date=2017-11-01&rft.issn=1552-5783&rft.eissn=1552-5783&rft.volume=58&rft.issue=13&rft.spage=5713&rft_id=info:doi/10.1167%2Fiovs.17-22865&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon |